{"id":"doi:10.1038/nrclinonc.2018.29","kind":"review","title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","authors":["Dai Fukumura","Jonas Kloepper","Zohreh Amoozgar","Dan Gabriel Duda","Rakesh K. Jain"],"author_count":5,"year":2018,"published":"2018-03-06","venue":"Nature Reviews Clinical Oncology","cited_by":2026,"doi":"10.1038/nrclinonc.2018.29","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/nrclinonc.2018.29","archive_url":"https://space-kitty.com/papers/doi:10.1038/nrclinonc.2018.29","updated":null,"pmid":"29508855","pmcid":null,"openalex_id":"W2791328450","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Angiogenesis and VEGF in Cancer"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"cancer-immunotherapy","title":"Cancer Immunotherapy: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/cancer-immunotherapy"}]}